Regen BioPharma, Inc. (RGBPP)

USD 0.08

(0.0%)

Market Cap (In USD)

2.98 Million

Revenue (In USD)

236.56 Thousand

Net Income (In USD)

1.02 Million

Avg. Volume

14.26 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.03-1.173333
PE
-
EPS
-
Beta Value
2.853
ISIN
US75886M4096
CUSIP
75886M201
CIK
1589150
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. David Raymond Koos DBA, Ph.D.
Employee Count
-
Website
https://www.regenbiopharmainc.com
Ipo Date
2016-04-20
Details
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.